S&P 500 Futures
(-0.58%) 5 078.00 points
Dow Jones Futures
(-0.40%) 38 527 points
Nasdaq Futures
(-0.87%) 17 511 points
Oil
(0.02%) $82.83
Gas
(-0.24%) $1.649
Gold
(0.03%) $2 339.20
Silver
(0.22%) $27.41
Platinum
(-0.02%) $915.60
USD/EUR
(-0.24%) $0.932
USD/NOK
(-0.27%) $10.95
USD/GBP
(-0.42%) $0.799
USD/RUB
(-0.26%) $92.08

Realtime updates for Vaxart Inc [VXRT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
100.00%
return 8.22%
SELL
50.00%
return -0.71%
Last Updated24 Apr 2024 @ 16:00

-4.79% $ 0.710

SELL 104524 min ago

@ $1.235

Issued: 12 Feb 2024 @ 15:35


Return: -42.53%


Previous signal: Feb 12 - 14:01


Previous signal: Buy


Return: 2.06 %

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):
Profile picture for Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform...

Stats
Today's Volume 1.45M
Average Volume 1.95M
Market Cap 125.50M
EPS $0 ( 2024-03-14 )
Next earnings date ( $-0.160 ) 2024-05-02
Last Dividend $12.19 ( 2012-11-09 )
Next Dividend $0 ( N/A )
P/E -1.250
ATR14 $0.00300 (0.43%)
Insider Trading
Date Person Action Amount type
2023-03-28 Tucker Sean Buy 0
2024-03-28 Tucker Sean Sell 3 902 Common Stock
2024-03-28 Cummings James F. Sell 3 292 Common Stock
2024-03-18 Tucker Sean Buy 90 000 Common Stock
2024-03-18 Tucker Sean Buy 410 000 Stock Option (right to buy)
INSIDER POWER
94.60
Last 95 transactions
Buy: 10 890 181 | Sell: 279 805

Volume Correlation

Long: -0.22 (neutral)
Short: 0.58 (weak)
Signal:(45.025) Neutral

Vaxart Inc Correlation

10 Most Positive Correlations
LYEL0.934
LYRA0.93
TCRT0.92
FATE0.92
WISA0.915
GROM0.914
AFMD0.914
ARQQ0.914
GRNA0.913
AVO0.912
10 Most Negative Correlations
LRFC-0.93
STAY-0.928
GLLI-0.907
IBEX-0.905
XOMAO-0.899
XOMAP-0.898
CHPM-0.898
BCOR-0.895
MNKD-0.893
CIIG-0.891

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vaxart Inc Correlation - Currency/Commodity

The country flag 0.68
( moderate )
The country flag 0.67
( moderate )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Vaxart Inc Financials

Annual 2023
Revenue: $7.38M
Gross Profit: $2.88M (39.02 %)
EPS: $-0.570
Q4 2023
Revenue: $3.25M
Gross Profit: $2.05M (63.02 %)
EPS: $-0.110
Q3 2023
Revenue: $446 000
Gross Profit: $-754 000 (-169.06 %)
EPS: $-0.110
Q2 2023
Revenue: $1.36M
Gross Profit: $231 000 (17.01 %)
EPS: $-0.160

Financial Reports:

No articles found.

Vaxart Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Vaxart Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $12.19 2012-11-09
Last Dividend $12.19 2012-11-09
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out $12.19 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-04-25)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2012 $12.19 9.77%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-14.411.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.8981.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-1.0851.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.320.80010.008.00[1 - 3]
quickRatioTTM3.110.80010.008.00[0.8 - 2.5]
cashRatioTTM2.531.50010.0010.00[0.2 - 2]
debtRatioTTM0.0994-1.5008.34-10.00[0 - 0.6]
interestCoverageTTM-57.601.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM-0.4592.00-0.153-0.306[0 - 30]
freeCashFlowPerShareTTM-0.4712.00-0.236-0.471[0 - 20]
debtEquityRatioTTM0.158-1.5009.37-10.00[0 - 2.5]
grossProfitMarginTTM0.1961.000-0.0722-0.0722[0.2 - 0.8]
operatingProfitMarginTTM-14.561.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-7.721.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.06230.800-2.92-2.33[0.5 - 2]
Total Score-1.818

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.3211.000-0.2340[1 - 100]
returnOnEquityTTM-1.0852.50-8.46-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-0.4712.00-0.157-0.471[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.4592.00-0.153-0.306[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM-12.311.000-10.000[0.1 - 0.5]
Total Score-2.59

Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. The company is headquartered in South San Francisco, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators